Haemonetics Corporation Provided Earnings Guidance for the fiscal year 2022. Total company GAAP revenue guidance includes $75 - $85 million revenue related to Vascular Closure. Hospital organic revenue guidance includes a Hemostasis Management organic revenue growth in the mid-twenties. Organic total revenue expected to be in the range of 8% to 12%.